Cargando…
Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts
BACKGROUND: Human infection with avian influenza H7N9 virus was first reported in 2013. Since the fifth epidemic, a highly pathogenic avian influenza (HPAI) H7N9 virus has emerged and caused 33 human infections. Several potential NAI resistance sites have been found in human cases. However, the drug...
Autores principales: | Tang, Jing, Zhang, Jing, Zhou, Jianfang, Zhu, Wenfei, Yang, Lei, Zou, Shumei, Wei, Hejiang, Xin, Li, Huang, Weijuan, Li, Xiyan, Cheng, Yanhui, Wang, Dayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604316/ https://www.ncbi.nlm.nih.gov/pubmed/31266524 http://dx.doi.org/10.1186/s12985-019-1194-9 |
Ejemplares similares
-
Biological characterisation of the emerged highly pathogenic avian influenza
(HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017
por: Zhu, Wenfei, et al.
Publicado: (2017) -
Homologous PB1 gene promotes the replication efficiency of avian influenza H7N4 candidate vaccine virus
por: Liu, Liqi, et al.
Publicado: (2022) -
Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice
por: Tang, Jing, et al.
Publicado: (2021) -
The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019
por: Yu, Deshan, et al.
Publicado: (2019) -
Characterization of Influenza Viruses — China, 2019−2020
por: Huang, Weijuan, et al.
Publicado: (2020)